Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NESS ZIONA, Israel (May 31, 2013) – Kamada Ltd. today announced the pricing of its initial public offering in the United States of 5582636 ordinary shares at a price to the public of $9.25 per ordinary share. Shares of Kamada’s common stock are scheduled to begin trading on the NASDAQ Global Select Market under the symbol KMDA on May 31 2013. All of the shares of common stock are being offered by Kamada. In addition Kamada has granted the underwriters a 30-day option to purchase up to an additional 837395 shares of common stock to cover over-allotments if any.
Morgan Stanley & Co. LLC and Jefferies LLC are acting as the representatives of the underwriters and joint book-running managers for the offering. RBC Capital Markets LLC and Oppenheimer & Co. Inc. are acting as co-managers.
A registration statement relating to this offering has been filed with and declared effective by the Securities and Exchange Commission. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities nor shall there be any sale of these securities in any state or jurisdiction in which such offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
This offering is being made only by means of a prospectus copies of which may be obtained from:
Morgan Stanley & Co. LLC180 Varick Street 2nd FloorNew York NY 10014Attention: Prospectus Department(866) 718-1649prospectus@morganstanley.com
Jefferies LLC520 Madison AvenueNew York NY 10022Attention: Prospectus Department(877) 547-4340Prospectus_Department@jefferies.com
Shares of Kamada also trade on the Tel Aviv Stock Exchange under the symbol KMDA.
Help employers find you! Check out all the jobs and post your resume.
